Cargando…
A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells in vitro
Malignant melanoma is characterized by suppressed apoptosis in tumor cells and high levels of invasion. Temozolomide (TMZ) is one of the most effective single chemotherapeutic agents for patients with malignant melanoma, but resistance develops quickly and frequently. Therapeutic cytokines such as i...
Autores principales: | Liang, Zhen, Yang, Chun-Sheng, Gu, Feng, Zhang, Lan-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453041/ https://www.ncbi.nlm.nih.gov/pubmed/28599419 http://dx.doi.org/10.3892/ol.2017.6007 |
Ejemplares similares
-
Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL‐24 enhances the antitumor effect of temozolomide against melanoma
por: Yang, Ming, et al.
Publicado: (2018) -
Siderol Inhibits Proliferation of Glioblastoma Cells and Acts Synergistically with Temozolomide
por: Giannakopoulou, Maria, et al.
Publicado: (2022) -
Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer
por: Nelson, Amy R, et al.
Publicado: (2009) -
IL-24 Induces Apoptosis via Upregulation of RNA-Activated Protein Kinase and Enhances Temozolomide-Induced Apoptosis in Glioma Cells
por: Hu, Chang-Wei, et al.
Publicado: (2015) -
Temozolomide induces senescence but not apoptosis in human melanoma cells
por: Mhaidat, N M, et al.
Publicado: (2007)